S&P 500   4,559.35 (-0.23%)
DOW   36,067.10 (-0.38%)
QQQ   386.18 (-0.04%)
AAPL   193.58 (+2.19%)
MSFT   371.60 (+0.67%)
META   317.06 (-0.92%)
GOOGL   130.73 (+1.13%)
AMZN   146.01 (+0.81%)
TSLA   241.85 (+2.66%)
NVDA   460.28 (+1.14%)
NIO   7.53 (+2.87%)
BABA   72.23 (-1.10%)
AMD   117.36 (-1.02%)
T   17.21 (+3.30%)
F   10.63 (-0.65%)
MU   73.62 (-0.90%)
CGC   0.64 (-15.26%)
GE   120.70 (-0.68%)
DIS   90.15 (-2.02%)
AMC   6.92 (-7.61%)
PFE   29.13 (-0.51%)
PYPL   57.56 (-3.83%)
XOM   101.06 (-1.34%)
S&P 500   4,559.35 (-0.23%)
DOW   36,067.10 (-0.38%)
QQQ   386.18 (-0.04%)
AAPL   193.58 (+2.19%)
MSFT   371.60 (+0.67%)
META   317.06 (-0.92%)
GOOGL   130.73 (+1.13%)
AMZN   146.01 (+0.81%)
TSLA   241.85 (+2.66%)
NVDA   460.28 (+1.14%)
NIO   7.53 (+2.87%)
BABA   72.23 (-1.10%)
AMD   117.36 (-1.02%)
T   17.21 (+3.30%)
F   10.63 (-0.65%)
MU   73.62 (-0.90%)
CGC   0.64 (-15.26%)
GE   120.70 (-0.68%)
DIS   90.15 (-2.02%)
AMC   6.92 (-7.61%)
PFE   29.13 (-0.51%)
PYPL   57.56 (-3.83%)
XOM   101.06 (-1.34%)
S&P 500   4,559.35 (-0.23%)
DOW   36,067.10 (-0.38%)
QQQ   386.18 (-0.04%)
AAPL   193.58 (+2.19%)
MSFT   371.60 (+0.67%)
META   317.06 (-0.92%)
GOOGL   130.73 (+1.13%)
AMZN   146.01 (+0.81%)
TSLA   241.85 (+2.66%)
NVDA   460.28 (+1.14%)
NIO   7.53 (+2.87%)
BABA   72.23 (-1.10%)
AMD   117.36 (-1.02%)
T   17.21 (+3.30%)
F   10.63 (-0.65%)
MU   73.62 (-0.90%)
CGC   0.64 (-15.26%)
GE   120.70 (-0.68%)
DIS   90.15 (-2.02%)
AMC   6.92 (-7.61%)
PFE   29.13 (-0.51%)
PYPL   57.56 (-3.83%)
XOM   101.06 (-1.34%)
S&P 500   4,559.35 (-0.23%)
DOW   36,067.10 (-0.38%)
QQQ   386.18 (-0.04%)
AAPL   193.58 (+2.19%)
MSFT   371.60 (+0.67%)
META   317.06 (-0.92%)
GOOGL   130.73 (+1.13%)
AMZN   146.01 (+0.81%)
TSLA   241.85 (+2.66%)
NVDA   460.28 (+1.14%)
NIO   7.53 (+2.87%)
BABA   72.23 (-1.10%)
AMD   117.36 (-1.02%)
T   17.21 (+3.30%)
F   10.63 (-0.65%)
MU   73.62 (-0.90%)
CGC   0.64 (-15.26%)
GE   120.70 (-0.68%)
DIS   90.15 (-2.02%)
AMC   6.92 (-7.61%)
PFE   29.13 (-0.51%)
PYPL   57.56 (-3.83%)
XOM   101.06 (-1.34%)

Avantor Stock Price, News & Analysis (NYSE:AVTR)

$20.62
-0.82 (-3.82%)
(As of 12:39 PM ET)
Compare
Today's Range
$20.62
$21.36
50-Day Range
$17.15
$21.57
52-Week Range
$16.63
$25.25
Volume
2.26 million shs
Average Volume
6.81 million shs
Market Capitalization
$13.95 billion
P/E Ratio
38.19
Dividend Yield
N/A
Price Target
$24.05

Avantor MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.73 Rating Score
Upside/​Downside
14.4% Upside
$24.05 Price Target
Short Interest
Bearish
4.68% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-2.12
Upright™ Environmental Score
News Sentiment
0.56mentions of Avantor in the last 14 days
Based on 16 Articles This Week
Insider Trading
Selling Shares
$156,389 Sold Last Quarter
Proj. Earnings Growth
6.73%
From $1.04 to $1.11 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.07 out of 5 stars

Medical Sector

546th out of 955 stocks

Analytical Instruments Industry

15th out of 28 stocks


AVTR stock logo

About Avantor Stock (NYSE:AVTR)

Avantor, Inc. engages in the provision of mission-critical products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides logistics, chemical and equipment tracking, and glassware autoclaving, as well as scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

AVTR Stock Price History

AVTR Stock News Headlines

Avantor, Inc. (NYSE:AVTR) Sees Large Increase in Short Interest
Countries Are Investing Heavily Into Securing Energy Independence
There's a worldwide "arms race" for countries to secure lithium - the critical metal essential to powering the world's green energy transition. While the U.S. is now investing heavily into lithium production, the North American supply chain has fallen far behind. One company is on a mission to change that and make a previously remote area the next great lithium mining hub.
Countries Are Investing Heavily Into Securing Energy Independence
There's a worldwide "arms race" for countries to secure lithium - the critical metal essential to powering the world's green energy transition. While the U.S. is now investing heavily into lithium production, the North American supply chain has fallen far behind. One company is on a mission to change that and make a previously remote area the next great lithium mining hub.
Avantor® to Host Investor Day on December 8, 2023
The Avantor Inc (AVTR) Company: A Short SWOT Analysis
Avantor, Inc Q3 Profit Drops, Inline With Estimates
Avantor, Inc. (AVTR) Q3 Earnings Meet Estimates
Avantor earnings: here's what Wall Street expects
Women of Influence 2023: Deborah Poenisch, Avantor
See More Headlines
Receive AVTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avantor and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/27/2023
Today
12/05/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/02/2024

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
14,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$24.05
High Stock Price Target
$30.00
Low Stock Price Target
$21.00
Potential Upside/Downside
+12.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.73
Research Coverage
11 Analysts

Profitability

Net Income
$686.50 million
Pretax Margin
6.62%

Debt

Sales & Book Value

Annual Sales
$7.51 billion
Cash Flow
$2.05 per share
Book Value
$7.20 per share

Miscellaneous

Free Float
666,240,000
Market Cap
$14.51 billion
Optionable
Not Optionable
Beta
1.36
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report














AVTR Stock Analysis - Frequently Asked Questions

Should I buy or sell Avantor stock right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last twelve months. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AVTR shares.
View AVTR analyst ratings
or view top-rated stocks.

What is Avantor's stock price target for 2024?

11 brokerages have issued 12-month target prices for Avantor's shares. Their AVTR share price targets range from $21.00 to $30.00. On average, they predict the company's stock price to reach $24.05 in the next twelve months. This suggests a possible upside of 14.4% from the stock's current price.
View analysts price targets for AVTR
or view top-rated stocks among Wall Street analysts.

How have AVTR shares performed in 2023?

Avantor's stock was trading at $21.09 at the beginning of 2023. Since then, AVTR shares have decreased by 0.3% and is now trading at $21.02.
View the best growth stocks for 2023 here
.

Are investors shorting Avantor?

Avantor saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 31,680,000 shares, an increase of 9.1% from the October 31st total of 29,040,000 shares. Based on an average daily volume of 7,580,000 shares, the short-interest ratio is presently 4.2 days.
View Avantor's Short Interest
.

When is Avantor's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, February 2nd 2024.
View our AVTR earnings forecast
.

How were Avantor's earnings last quarter?

Avantor, Inc. (NYSE:AVTR) released its quarterly earnings data on Friday, October, 27th. The company reported $0.25 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.25. The firm earned $1.72 billion during the quarter, compared to the consensus estimate of $1.70 billion. Avantor had a net margin of 5.18% and a trailing twelve-month return on equity of 15.34%. The company's revenue was down 7.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.34 EPS.

What guidance has Avantor issued on next quarter's earnings?

Avantor updated its FY 2023 earnings guidance on Friday, October, 27th. The company provided EPS guidance of $1.02-$1.06 for the period, compared to the consensus EPS estimate of $1.07. The company issued revenue guidance of -.

What other stocks do shareholders of Avantor own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avantor investors own include Johnson & Johnson (JNJ), NVIDIA (NVDA), Procter & Gamble (PG), RTX (RTX), Alibaba Group (BABA), CVS Health (CVS), Home Depot (HD), Pfizer (PFE) and QUALCOMM (QCOM).

When did Avantor IPO?

(AVTR) raised $3 billion in an initial public offering on Friday, May 17th 2019. The company issued 154,000,000 shares at a price of $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies served as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Who are Avantor's major shareholders?

Avantor's stock is owned by a variety of institutional and retail investors. Top institutional investors include Boston Partners (4.15%), Canada Pension Plan Investment Board (3.30%), Wellington Management Group LLP (1.34%), Meritage Group LP (1.32%), Robeco Schweiz AG (1.21%) and American Century Companies Inc. (1.13%). Insiders that own company stock include Christi Shaw, Christophe Couturier, David D Petratis, Devashish Ohri, Frederic Vanderhaegen, Gerard Brophy, James Bramwell, Jo Natauri, Justin Miller, Michael Stubblefield, Michael Wondrasch, Rajiv Gupta, Steven W Eck and Thomas A Szlosek.
View institutional ownership trends
.

How do I buy shares of Avantor?

Shares of AVTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:AVTR) was last updated on 12/5/2023 by MarketBeat.com Staff

My Account -